Inhibition of oxidative drug metabolism by beta‐adrenoceptor antagonists in related to their lipid solubility [letter]
Open Access
- 1 September 1981
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 12 (3) , 429-431
- https://doi.org/10.1111/j.1365-2125.1981.tb01240.x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An investigation of the comparative liposolubilities of β-adrenoceptor blocking agentsJournal of Pharmacy and Pharmacology, 1981
- Beta‐adrenoceptor blockers and the blood‐brian barrier.British Journal of Clinical Pharmacology, 1981
- Is there a relationship between the physical properties and cardioselectivity of beta-adrenoceptor antagonists?Published by Wiley ,1981
- Kinetics and Biotransformation of Adrenergic InhibitorsPublished by Springer Nature ,1981
- PHARMACOKINETIC INTERACTION BETWEEN PROPRANOLOL AND CHLORPROMAZINE IN SCHIZOPHRENIC PATIENTSThe Lancet, 1980
- Interaction of a series of β-adrenergic blocking drugs with rat hepatic microsomal monooxygenasePharmacological Research Communications, 1979
- Impairment of antipyrine clearance in humans by propranolol.Circulation, 1978
- Clinical Pharmacokinetics of β-Adrenoreceptor Blocking DrugsClinical Pharmacokinetics, 1976
- Lack of biological interaction of alprenolol and salicylate in manEuropean Journal of Clinical Pharmacology, 1973
- Relationship between difference spectra and metabolism: Barbiturates, drug interaction and species differenceBiochemical Pharmacology, 1970